Phase 3 trial in 18,746 adults finds Pfizer’s mRNA flu shot 34.5% more effective than standard vaccines for influenza A, while results for influenza B remain inconclusive, and mild to moderate side effects occur more often in the mRNA group. 💉🦠📊
Read Full Article
#PfizerFluVaccine #mRNATechnology #InfluenzaResearch #VaccineEffectiveness #PublicHealth
Read Full Article
#PfizerFluVaccine #mRNATechnology #InfluenzaResearch #VaccineEffectiveness #PublicHealth
The New England Journal of Medicine
Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine | NEJM
Influenza remains a major health burden despite the use of licensed vaccines. Nucleoside-modified
messenger RNA (modRNA) influenza vaccines have shown promising immunogenicity against
influenza and...
messenger RNA (modRNA) influenza vaccines have shown promising immunogenicity against
influenza and...
🖕1